Danimer Scientific Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Danimer Scientific şirketinin toplam hissedar öz sermayesi $211.6M ve toplam borcu $387.9M olup, bu da borç-öz sermaye oranını 183.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $643.8M ve $432.2M dir.

Anahtar bilgiler

183.3%

Borç/özkaynak oranı

US$387.90m

Borç

Faiz karşılama oranı	n/a
Nakit	US$22.19m
Eşitlik	US$211.59m
Toplam yükümlülükler	US$432.18m
Toplam varlıklar	US$643.77m

Son finansal sağlık güncellemeleri

Recent updates

News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts

May 21

Danimer Scientific, Inc. (NYSE:DNMR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

May 10

Broker Revenue Forecasts For Danimer Scientific, Inc. (NYSE:DNMR) Are Surging Higher

Apr 25

Danimer Scientific Is In Trouble

Nov 17

Danimer Scientific: It's Not Time To Buy

Sep 05

Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream

Jun 20

Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)

May 15

Danimer Scientific: Falling Momentum As Cash Burn Climbs

Dec 19

What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Nov 17

Danimer Scientific: Biodegradable Plastics Are Still Important

Sep 30

Danimer Scientific stock slides on $100M securities offering

Aug 26

These Analysts Think Danimer Scientific, Inc.'s (NYSE:DNMR) Sales Are Under Threat

Aug 17

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: DNMR 'nin kısa vadeli varlıkları ( $69.9M ) kısa vadeli yükümlülüklerini ( $21.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: DNMR 'un kısa vadeli varlıkları ( $69.9M ) uzun vadeli yükümlülüklerini ( $410.8M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: DNMR 'nin net borç/öz sermaye oranı ( 172.8% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: DNMR 'nin borç/öz sermaye oranı son 5 yılda 400.1% seviyesinden 183.3% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: DNMR şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: DNMR un, serbest nakit akışı her yıl % 12.6 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Danimer Scientific Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Danimer Scientific, Inc. announced delayed 10-Q filing

Danimer Scientific Announces Intention to Complete a Reverse Stock Split to Regain Compliance with the Price Criteria of Section 802.01C of the NYSE Listed Company Manual

Danimer Scientific, Inc. Receives Non-Compliance Notice from NYSE Regulation

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

Recent updates

Danimer Scientific, Inc. announced delayed 10-Q filing

Danimer Scientific Announces Intention to Complete a Reverse Stock Split to Regain Compliance with the Price Criteria of Section 802.01C of the NYSE Listed Company Manual

High number of new directors

Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit

Danimer Scientific, Inc. to Report Q3, 2024 Results on Nov 14, 2024

Price target decreased by 25% to US$0.85

New major risk - Share price stability

Consensus revenue estimates decrease by 44%, EPS upgraded

Price target decreased by 12% to US$1.33

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Danimer Scientific, Inc. Provides Financial Guidance for the Second Quarter of Fiscal 2025

Danimer Scientific, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Danimer Scientific, Inc.(UNQ:) dropped from Russell 2000 Value Index

Danimer Scientific, Inc. Receives Non-Compliance Notice from NYSE Regulation

Price target decreased by 10% to US$1.41

News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts

Consensus revenue estimates fall by 22%

Danimer Scientific, Inc. (NYSE:DNMR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

New major risk - Financial position

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Danimer Scientific Reveals New Branding and New Applications Based on PHA During NPE 2024

Danimer Scientific, Inc., Annual General Meeting, Jul 09, 2024

Danimer Scientific, Inc. to Report Q1, 2024 Results on May 07, 2024

Broker Revenue Forecasts For Danimer Scientific, Inc. (NYSE:DNMR) Are Surging Higher

Consensus revenue estimates increase by 11%

New minor risk - Market cap size

Consensus revenue estimates decrease by 25%, EPS upgraded

Price target decreased by 14% to US$2.22

Full year 2023 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $14.999625 million.

New minor risk - Shareholder dilution

Danimer Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $34.95 million.

New major risk - Share price stability

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

Danimer Scientific Receives Continued Listing Standard Notice from NYSE

Danimer Scientific, Inc. Announces New Directors

Independent Director recently bought US$93k worth of stock

New minor risk - Market cap size

Consensus revenue estimates fall by 21%

Price target decreased by 11% to US$4.20

Danimer Scientific Is In Trouble

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Danimer Scientific, BIOLO and Bolthouse Farms Announce Commercialization of Home Compostable Packaging for Fresh Produce with Meijer Stores

Danimer Scientific: It's Not Time To Buy

Price target decreased by 13% to US$4.60

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. to Report Q2, 2023 Results on Aug 08, 2023

New major risk - Financial position

Price target decreased by 8.8% to US$5.30

Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream

Consensus revenue estimates fall by 16%

Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Danimer Scientific, Inc. to Report Q1, 2023 Results on May 10, 2023

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Chief Financial Officer exercised options and sold US$61k worth of stock

Danimer Scientific: Falling Momentum As Cash Burn Climbs

What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates

Price target decreased to US$6.13

Price target decreased to US$6.13

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Danimer Scientific, Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2022

Danimer Scientific, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Danimer Scientific: Biodegradable Plastics Are Still Important

Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary

Danimer Scientific stock slides on $100M securities offering

Director recently sold US$873k worth of stock

Insider notifies of intention to sell stock

These Analysts Think Danimer Scientific, Inc.'s (NYSE:DNMR) Sales Are Under Threat